|
1
|
Mahjoubi M, Azab M, Ghosn M, Theodore C
and Droz JP: Phase II trial of ifosfamide in the treatment of
metastatic hormone-refractory patients with prostatic cancer.
Cancer Invest. 8:477–481. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kroemer G and Pouyssegur J: Tumor cell
metabolism: cancer ‘Achilles’ heel. Cancer Cell. 13:472–482. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Warburg O, Posener K and Negelein E: Ueber
den stoffwechsel dercarcinomzelle. Biochem Z. 152:309–344.
1924.
|
|
4
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mayevsky A: Mitochondrial function and
energy metabolism in cancer cells: past overview and future
perspectives. Mitochondrion. 9:165–179. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: the next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jiang XZ, Yan LN, Sun GY, Zhao SY, Gu JM,
Lei KJ, Zhu Y and Wang CS: Expression of hypoxia-inducible factor-1
alpha, hexokinase-II and lactate dehydrogenase-V in hepatocellular
carcinoma and their biological significance. Chin J Cancer Prev
Treat. 1:41–44. 2013.
|
|
8
|
Fan YX, Shi WM, Li J, Yin JL, Yang CH,
Huang KL, Liu QZ, Li KB and Wu JZ: Relationship between
fluorodeoxyglucose uptake and overexpression of glucose transport
protein 1 and hexokinase-II in early-stage nasopharyngeal
carcinoma. Chin J Nucl Medi. 30:166–169. 2010.
|
|
9
|
Herrala AM, Porvari KS, Kyllönen AP and
Vihko PT: Comparison of human prostate specific glandular
kallikrein 2 and prostate specific antigen gene expression in
prostate with gene amplification and overexpression of prostate
specific glandular kallikrein 2 in tumor tissue. Cancer.
92:2975–2984. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
He HC, Bi XC, Zheng ZW, Dai QS, Han ZD,
Liang YX, Ye YK, Zeng GH, Zhu G and Zhong WD: Real-time
quantitative RT-PCR assessment of PIM-1 and HK2 mRNA expression in
benign prostate hyper-plasia and prostate cancer. Med Oncol.
26:303–308. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pedersen PL: Warburg, me and Hexokinase 2:
Multiple discoveries of key molecular events underlying one of
cancers most common phenotypes, the ‘Warburg effect’, i.e.,
elevated glycolysis in the presence of oxygen. J Bioenerg
Biomember. 39:211–222. 2007. View Article : Google Scholar
|
|
12
|
Bhaskar PT and Hay N: The two TORCs and
Akt. Dev Cell. 12:487–502. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang ZT, Peng H, Li CY, Liu JJ, Zhou TT,
Yan YF, Li Y and Bao JK: Polygonatum cyrtonema lectin induces
murine fibrosarcoma L929 cell apoptosis via a caspasedependent
pathway as compared to ophiopogon japonicus lectin. Phytomedicine.
18:25–31. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu B, Wu JM, Li J, Liu JJ, Li WW, Li CY,
Xu HL and Bao JK: Polygonatum cyrtonema lectin induces murine
fibrosarcoma L929 cell apoptosis and autophagy via blocking Ras-Raf
and PI3K-Akt signaling pathways. Biochimie. 92:1934–1938. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu B, Cheng Y, Zhang B, Bian HJ and Bao
JK: Polygonatum cyrtonema lectin induces apoptosis and autophagy in
human melanoma A375 cells through a mitochondria-mediated
ROS-p38-p53 pathway. Cancer Lett. 275:54–60. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ferguson KM, Berger MB, Mendrola JM, Cho
HS, Leahy DJ and Lemmon MA: EGF activates its receptor by removing
interactions that auto-inhibit ectodomain dimerization. Mol Cell.
11:507–517. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ding JJ, Bao JK, Zhu DY, Zhang Y and Wang
DC: Crystal structures of a novel anti-HIV mannose-binding lectin
from Polygonatum cyrtonema Hua with unique ligand-binding property
and super-structure. J Struct Biol. 171:309–317. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kozakov D, Beglov D, Bohnuud T, Mottarella
SE, Xia B, Hall DR and Vajda S: How good is automated protein
docking? Proteins. 81:2159–2166. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kozakov D, Brenke R, Comeau SR and Vajda
S: PIPER: An FFT-based protein docking program with pairwise
potentials. Proteins. 65:392–406. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Comeau SR, Gatchell DW, Vajda S and
Camacho CJ: ClusPro: an automated docking and discrimination method
for the prediction of protein complexes. Bioinformatics. 20:45–50.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Comeau SR, Gatchell DW, Vajda S and
Camacho CJ: ClusPro: a fully automated algorithm for
protein-protein docking. Nucl Acids Res. 32:W96–W99. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bao JK, Zeng ZK and Zhou H: Purification
and characterization of the polygonatum cyrtonema Hua. Lectin II.
Chin Biochem J. 12:165–170. 1996.
|
|
23
|
Velpula KK, Bhasin A, Asuthkar S and Tsung
AJ: Combined targeting of PDKi and EGFR triggers regression of
glioblastoma by reversing the Warburg effect. Cancer Res.
73:7277–7289. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Toschi A, Lee E, Thompson S, Gadir N,
Yellen P, drain C Michael, Ohh M and Foster DA: Phospholipase
D-mTOR requirement for the Warburg effect in human cancer cells.
Cancer Lett. 299:72–79. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Barducci A, Bussi G and Parrinello M:
Well-tempered metadynamics: A smoothly converging and tunable
free-energy method. Phys Rev Lett. 100:0206032008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ilott AJ, Palucha S, Hodgkinson P and
Wilson MR: Well-tempered metadynamics as a tool for characterizing
multi-component, crystalline molecular machines. J Phys Chem B.
117:12286–12295. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Phillips JC, Braun R, Wang W, Gumbart J,
Tajkhorshid E, Villa E, Chipot C, Skeel RD, Kalé L and Schulten K:
Scalable molecular dynamics with NAMD. J Comput Chem. 26:1781–1802.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bonomi M, Branduardi D, Bussi G, Camilloni
C, Provasi D, Raiteri P, Donadio D, Marinelli F, Pietrucci F,
Broglia RA and Parrinello M: Plumed: A portable plugin for
free-energy calculations with molecular dynamics. Comput Phys
Commun. 180:1961–1972. 2009. View Article : Google Scholar
|
|
29
|
Darden T, York D and Pedersen L: Particle
mesh Ewald: An N•log(N) method for Ewald sums in large systems. J
Chem Phys. 98:10089–10092. 1993. View
Article : Google Scholar
|
|
30
|
Adelman SA and Doll JD: Generalized
langevin equation approach for atom/solid-surface scattering:
general formulation for classical scattering off harmonic solids. J
Chem Phys. 64:2375–2388. 1976. View
Article : Google Scholar
|
|
31
|
Davidchack RL, Handel R and Tretyakov MV:
Langevin thermostat for rigid body dynamics. J Chem Phys.
130:2341012009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Feller SE, Zhang Y, Pastor RW and Brooks
BR: Constant pressure molecular dynamics simulation: the Langevin
piston method. J Chem Phys. 103:4613–4621. 1995. View Article : Google Scholar
|
|
33
|
Cornell WD, Cleplak P and Bayly CI: A
second generation force field for the simulation of proteins,
nucleic acids, and organic molecules. J Am Chem Soc. 117:5179–5197.
1995. View Article : Google Scholar
|
|
34
|
Liu B, Cheng Y, Bian HJ and Bao JK:
Molecular mechanisms of Polygonatum cyrtonema lectin-induced
apoptosis and autophagy in cancer cells. Autophagy. 5:253–255.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kirkwood JG: Statistical mechanics of
fluid mixtures. J Chem Phys. 3:300–313. 1935. View Article : Google Scholar
|
|
36
|
Mathupala SP, Ko YH and Pedersen PL:
Hexokinase-2 bound to mitochondria: cancer's stygian link to the
‘Warburg Effect’ and a pivotal target for effective therapy. Semin
Cancer Biol. 19:17–24. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang L, Xiong H, Wu F, Zhang Y, Wang J,
Zhao L, Guo X, Chang LJ, Zhang Y, You MJ, et al: Hexokinase
2-mediated Warburg effect is required for PTEN- and
p53-deficiency-driven prostate cancer growth. Cell Rep.
8:1461–1474. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Dong G, Mao Q, Xia W, Xu Y, Wang J, Xu L
and Jiang F: PKM2 and cancer: The function of PKM2 beyond
glycolysis. Oncol Lett. 11:1980–1986. 2016.PubMed/NCBI
|
